WHO WE ARE
As a family-held company, we are cognizant of how work shapes who we are and who we aspire to become.
WHO WE ARE Aspiration & Values Leadership Our defining moments Sustainability Code of conduct Global presence
OUR FOCUS
Building on our foundational expertise in carbohydrate chemistry and cell cycle biology, we develop innovative treatments for unmet patient needs, with a focus on iron metabolism and blood-related disorders.
OUR FOCUS Pharmaceuticals Carbohydrates Animal Health
PROGRAMMES
Discover our current research programme which highlight our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism.
PROGRAMMES Clinical Trials Petadeferitrin
CAREER
We are a fully integrated pharmaceutical company with many exciting opportunities ahead of us. Do you want to join us?
CAREER Job openings Life at Pharmacosmos
NEWS & MEDIA
We always strive to achieve new results and collaborations that can improve the quality of lives. Stay informed with our latest news and press releases.
NEWS & MEDIA News & Press Events Media
CONTACT US
We welcome all questions or inquiries. Get started by filling out a form or read about the way we are partnering.
CONTACT US Partnering with us Privacy policy

PROGRAMMES

Discover our current research programme, which highlights our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism and cell cycle biology.

At Pharmacosmos, we are committed to scientific progress in iron metabolism and blood-related disorders. Our research includes clinical studies aimed at expanding knowledge and exploring potential new treatment approaches. Through these programmes, we seek to contribute to the long-term understanding and management of these conditions.

Clinical Trials

Explore our clinical trials.

Petadeferitrin

Pharmacosmos is developing petadeferitrin, a small molecule iron chelator, as a potential new treatment for patients with transfusional iron overload.